Replies to post #302941 on Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

No it pertains to OxyContin patents only. If a combination has as a component an extended release oxy that was a generic equivalent of OxyContin then it might be the case, but run if the mill oxy IR is not covered